文献速递心外重症与机械循环支持

心室辅助装置桥接与性别不匹配增加心脏移植排斥并降低生存

Ventricular assist device bridging with gender-mismatch increases rejection and decreases survival following a heart transplant.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

结果显示VAD桥接合并性别不匹配者排斥率更高、生存更差,而无VAD者性别不匹配未显著影响生存。

要点

  • VAD桥接合并性别不匹配者移植后1年排斥率27.3%,高于性别匹配的23.3%。
  • 校正生存分析中VAD桥接性别不匹配者生存显著劣于性别匹配者。
  • 无VAD者中性别匹配与否的生存差异无统计学意义。

核心结论

  • VAD桥接与供受体性别不匹配组合导致移植后排斥增加且生存更差。

主要发现

  • 移植后1年排斥率VAD-M为23.3%、VAD-MM为27.3%(P < 0.01)。
  • 移植后1年排斥率noVAD-M为21.8%、noVAD-MM为23.6%(P = 0.02)。
  • 校正生存分析中VAD-MM组生存显著劣于VAD-M组(P < 0.01)。
  • noVAD-M与noVAD-MM组生存差异无统计学意义(P = 0.21)。

临床怎么用

  • VAD桥接患者行心脏移植时应重视供受体性别匹配以降低排斥风险。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Survival is poor following an orthotopic heart transplant with gender-mismatched donors and recipients. Patients bridged to an orthotopic heart transplant with a ventricular assist device (VAD) frequently become sensitized. We hypothesized that the combination of VAD bridging and gender-mismatch may result in greater rejection and poorer survival. METHODS: Data were obtained from the United Network of Organ Sharing database. Patients were divided into 4 groups: (i) VAD recipients who received a heart from a gender-matched donor (VAD-M); (ii) VAD recipients who received a heart from a gender-mismatched donor (VAD-MM); (iii) noVAD recipients who received a heart from a gender-matched donor (noVAD-M); and (iv) noVAD recipients who received a heart from a gender-mismatched donor (noVAD-MM). Rejection episodes within 1-year post-transplant and transplant survival were compared in VAD-M versus VAD-MM and noVAD-M versus noVAD-MM groups, respectively. RESULTS: Between January 2000 and June 2017, of 33 401 adult patients who underwent heart transplants, 8648, 2441, 12 761 and 4992 patients were identified as VAD-M, VAD-MM, noVAD-M and noVAD-MM, respectively. Rejection within 1-year post-transplant occurred in 23.3% and 27.3% of the VAD-M and VAD-MM groups, respectively (P < 0.01) and in 21.8% and 23.6% of the noVAD-M and noVAD-MM groups (P = 0.02), respectively. In an adjusted survival analysis, the VAD-MM group showed significantly worse survival than the VAD-M group (P < 0.01), whereas there was no significant difference between the noVAD-M and noVAD-MM groups (P = 0.21). CONCLUSIONS: Our results indicated that the combination of VAD bridging and gender-mismatch caused greater rejection and worse survival following a transplant. Further study is necessary to prove comparable post-transplant survival of gender-matched or -mismatched recipients without VAD bridging.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Itoda Y, Okamoto T, Niikawa H, et al. Ventricular assist device bridging with gender-mismatch increases rejection and decreases survival following a heart transplant. Eur J Cardiothorac Surg. 2021. PMID: 33057607. doi:10.1093/ejcts/ezaa270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。